Solensia™ is the first and only injectable monoclonal antibody (mAb) treatment for feline OA pain approved in the United States Monthly administration of Solensia controls OA pain by targeting Nerve ...

Add Yahoo as a preferred source to see more of our stories on Google. Some pet owners want a recall of a new arthritis drug for cats after their animals died, some in horrific ways, just days after ...

Arthritis can keep a cat from doing many of the things that kitties love to do. But now there's hope: The first treatment to ease arthritis pain in cats has been approved by the U.S. Food and Drug ...

For the first time, a drug aimed at treating osteoarthritis in cats has been approved for use in the U.S. It's also the first approved monoclonal antibody drug approved by the Food and Drug ...

Solensia is the first injectable monoclonal antibody (mAb) licensed for alleviation of pain associated with osteoarthritis (OA) in cats Solensia works as a monthly treatment targeting Nerve Growth ...

Add Yahoo as a preferred source to see more of our stories on Google. There are growing concerns over a new arthritis drug for cats. As reported on News Center 7 Daybreak, pets are dying after taking ...

Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted the marketing authorization for Solensia ® (frunevetmab), a new feline osteoarthritis treatment to alleviate pain.